Bloomberg~Kimmel Institute For Cancer Immunotherapy

Johns Hopkins Kimmel Cancer Center Immunotherapy Experts Named Bloomberg~Kimmel Professors

Posted by  | Research

Three Johns Hopkins Kimmel Cancer Center researchers were recognized as the first Bloomberg~Kimmel professors in cancer immunology during a ceremony at Johns Hopkins. The event marked the beginning of the Bloomberg~Kimmel Professorships program, and the three scientists were recognized for their work in precision immunotherapy, the bacterial contributions in the microbiome, and how targeting the(...)

Researchers Advance Role of Circulating Tumor DNA to Detect Early Melanoma Growth, Uncover Treatment Options

Posted by  | Research, treatment

Researchers at the Johns Hopkins Kimmel Cancer Center say they have added to evidence that measuring and monitoring tumor DNA that naturally circulates in the blood of melanoma patients can not only reliably help reveal the early stages of cancer growth and spread but also uncover new treatment options that tumor genetic analysis alone may(...)

Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer

Posted by  | Issues & Perspectives, Research, Survivorship

Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, her research and clinical practice focuses on the development of new therapies for the treatment and prevention(...)

Cancer Matters with Dr. Bill Nelson – Managing the Adverse Effects of Immunotherapy Treatment

Cancer Matters with Dr. Bill Nelson – Managing the Adverse Effects of Immunotherapy Treatment

Posted by  | podcast

In our next podcast, Dr Bill Nelson speaks to Dr Jarushka Naidoo about monitoring and treating the side effects of cancer immunotherapy treatment. In this preview, Dr Bill Nelson speaks to Dr Jarushka Naidoo about monitoring and treating the side effects of cancer immunotherapy treatment. To listen to the entire podcast, click here: https://bit.ly/2QKMFuo

Special Delivery Targets Brain Cancer Cells

Special Delivery Targets Brain Cancer Cells

Posted by  | Research

Pictured: Nanoparticles releasing microRNAs inside a brain cancer cell. Johns Hopkins Kimmel Cancer Center brain cancer researchers announced that they successfully delivered ultra-tiny nano-size packets of genetic code, called microRNAs, in animal models of human brain cancer. This multi-specialty study was led by John Laterra, M.D., Ph.D., co-director of the Kimmel Cancer Center Brain Cancer(...)